Filing Details

Accession Number:
0001104659-22-097866
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-06 16:26:24
Reporting Period:
2022-09-01
Accepted Time:
2022-09-06 16:26:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
275053 Natures Sunshine Products Inc NATR Pharmaceutical Preparations (2834) 870327982
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
899083 Wynnefield Partners Small Cap Value Lp 450 Seventh Avenue
Suite 509
New York NY 10123
No No Yes No
1017043 Nelson Obus 450 Seventh Avenue
Suite 509
New York NY 10123
No No Yes No
1030806 Ltd Fund Offshore Value Cap Small Wynnefield 450 Seventh Avenue
Suite 509
New York NY 10123
No No Yes No
1056835 Wynnefield Capital Management Llc 450 Seventh Avenue
Suite 509
New York NY 10123
No No Yes No
1251565 Wynnefield Partners Small Cap Value Lp I 450 Seventh Avenue
Suite 509
New York NY 10123
No No Yes No
1251567 Wynnefield Capital Inc 450 Seventh Avenue
Suite 509
New York NY 10123
No No Yes No
1251568 Joshua Landes 450 Seventh Avenue
Suite 509
New York NY 10123
No No Yes No
1289453 Wynnefield Capital, Inc. Profit Sharing Plan 450 Seventh Avenue
Suite 509
New York NY 10123
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Per Share (The "Common Stock") Acquisiton 2022-09-01 874 $9.53 769,640 No 4 P Direct
Common Stock Acquisiton 2022-09-01 1,911 $9.53 1,688,632 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2022-09-02 1,824 $9.51 771,646 No 4 P Direct
Common Stock Acquisiton 2022-09-02 3,990 $9.51 1,692,622 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect See Footnotes
No 4 P Direct
No 4 P Indirect See Footnotes
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $9.51-$9.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $9.47 to $9.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  3. The Reporting Person directly beneficially owns 771,646 shares of Common Stock of the Issuer. Wynnefield Capital Management, LLC, as the sole general partner of the Reporting Person, has an indirect beneficial ownership interest in the shares of Common Stock that the Reporting Person directly beneficially owns. Nelson Obus and Joshua Landes, as co-managing members of Wynnefield Capital Management, LLC, have an indirect beneficial ownership interest in the shares of Common Stock that the Reporting Person directly beneficially owns.
  4. The Reporting Person has an indirect beneficial ownership interest in 1,272,852 shares of Common Stock, which are directly beneficially owned by Wynnefield Partners Small Cap Value, L.P. I, as members of a group under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Wynnefield Partners Small Cap Value, L.P. I, which maintains offices at the same address as the Reporting Person, is filing this statement jointly with the Reporting Person. Wynnefield Capital Management, LLC, as the sole general partner of Wynnefield Partners Small Cap Value, L.P. I, has an indirect beneficial ownership interest in the shares of Common Stock that Wynnefield Partners Small Cap Value L.P. I directly beneficially owns. Nelson Obus and Joshua Landes, as co-managing members of Wynnefield Capital Management, LLC, have an indirect beneficial ownership interest in the shares of Common Stock that Wynnefield Partners Small Cap Value, L.P. I directly beneficially owns.
  5. The Reporting Person has an indirect beneficial ownership interest in 364,657 shares of Common Stock, which are directly beneficially owned by Wynnefield Small Cap Value Offshore Fund, Ltd., as members of a group under Section 13(d) of the Exchange Act. Wynnefield Small Cap Value Offshore Fund, Ltd., which maintains offices at the same address as the Reporting Person, is filing this statement jointly with the Reporting Person. Wynnefield Capital, Inc. as the sole investment manager of Wynnefield Small Cap Value Offshore Fund, Ltd., has an indirect beneficial ownership interest in the shares of Common Stock that Wynnefield Small Cap Value Offshore Fund, Ltd. directly beneficially owns. Nelson Obus and Joshua Landes, as principal executive officers of Wynnefield Capital, Inc., have an indirect beneficial ownership interest in the shares of Common Stock that Wynnefield Small Cap Value Offshore Fund, Ltd. directly beneficially owns.
  6. The Reporting Person has an indirect beneficial ownership interest in 55,113 shares of Common Stock, which are directly beneficially owned by Wynnefield Capital, Inc. Profit Sharing Plan, as members of a group under Section 13(d) of the Exchange Act. Wynnefield Capital, Inc. Profit Sharing Plan, which maintains offices at the same address as the Reporting Person, is filing this Form jointly with the Reporting Person. Mr. Obus and Mr. Landes, as co-trustees, has the power to vote and dispose of Wynnefield Capital, Inc. Profit Sharing Plan's investments in securities and has an indirect beneficial ownership interest in the shares of Common Stock that Wynnefield Capital, Inc. Profit Sharing Plan directly beneficially owns.